Mecanismos cirúrgicos de controle do diabetes mellitus tipo 2 após cirurgia bariátrica
Open Access
- 1 October 2007
- journal article
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 34 (5) , 343-346
Abstract
Type 2 diabetes mellitus is an epidemic health problem. Approximately, 90% of diabetic patients are overweight or are obese. The current increase in the prevalence of obesity has been associated with an increase in the prevalence of type 2 diabetes. Bariatric surgery is the most effective treatment for morbid obese patients in terms of controlling weight and co-morbidities. Sustained normal plasma concentration of glucose has been reported in most diabetic morbid obese patients, which has been managed surgically. Available data show a significant alteration in the production of some gastrointestinal hormones, which might explain the improvement of glucose metabolism following these procedures. Diabetic patient improvements following some bariatric surgeries seems to be an independent factor unrelated to the amount of weight loss. The authors reviewed data published on the effects of bariatric surgery in diabetic patient improvements and the possible mechanisms responsible for this control.Keywords
This publication has 43 references indexed in Scilit:
- Bariatric surgery: effects on glucose homeostasisCurrent Opinion in Clinical Nutrition and Metabolic Care, 2006
- Why Do Patients Lose Weight after Roux-en-Y Gastric Bypass?The Journal of Clinical Endocrinology & Metabolism, 2005
- The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose MetabolismAnnals of Surgery, 2004
- Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in WomenNew England Journal of Medicine, 2001
- Diabetes — a common, growing, serious, costly, and potentially preventable public health problemDiabetes Research and Clinical Practice, 2000
- Interactions between insulin resistance and insulin secretion in the development of glucose intoleranceJournal of Clinical Investigation, 2000
- Genetics of the metabolic syndromeBritish Journal of Nutrition, 2000
- Glucagon-Like PeptidesDiabetes, 1998
- The pathogenesis of NIDDM involves a defective expression of the GIP receptorDiabetologia, 1997
- Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.Journal of Clinical Investigation, 1989